Profile
David Gardner is currently the Head-EMEA Sales at iShares Plc.
Prior to this, he worked as a Director at Xilio Therapeutics, Inc. in 2021.
He also worked as an Analyst at BlackRock Advisors LLC from 2009 to 2011.
David Gardner active positions
| Companies | Position | Start |
|---|---|---|
iShares Plc
iShares Plc Investment Trusts/Mutual FundsMiscellaneous Exchange Traded Fund | Sales & Marketing | 20/10/2011 |
Former positions of David Gardner
| Companies | Position | End |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Director/Board Member | 01/10/2021 |
BlackRock Advisors LLC
BlackRock Advisors LLC Investment ManagersFinance BlackRock Advisors offers investors around the world a variety of investment products that span across asset classes, market-caps, investment styles and geographic regions. Their mandates include cash management, equity, fixed income, alternative, multi-asset and quantitative equity strategies. | Analyst-Equity | 09/09/2011 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
BlackRock Advisors LLC
BlackRock Advisors LLC Investment ManagersFinance BlackRock Advisors offers investors around the world a variety of investment products that span across asset classes, market-caps, investment styles and geographic regions. Their mandates include cash management, equity, fixed income, alternative, multi-asset and quantitative equity strategies. | Finance |
iShares Plc
iShares Plc Investment Trusts/Mutual FundsMiscellaneous Exchange Traded Fund | Miscellaneous |
Xilio Therapeutics, Inc.
Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
- Stock Market
- Insiders
- David Gardner
















